Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Catholic hospital sued for refusing to perform emergency abortion on a hemorrhaging patient
California Attorney General Rob Bonta is suing Providence St. Joseph Hospital to discourage an incident like this from happening in the future.
Newsom vetoes bill to regulate private equity transactions in healthcare
Assembly Bill 3129 would have given the California Attorney General oversight of all private equity investments or purchases involving a healthcare entity. Gov. Gavin Newsom argued that a similar regulatory framework is already in place.
FDA announces recall of Pfizer's fast-tracked sickle cell drug
The drugmaker is voluntarily withdrawing Oxbryta from the market due to a higher-than-acceptable risk of death.
Public health coalition wins lawsuit against EPA for lack of fluoride oversight
A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency.
Cardiology groups cheer new bill that would improve access to Medicare claims data
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

High valuations may curb healthcare M&A appetite of private equity groups

Healthcare M&A has been heating up for years, but sky-high valuations and rising competition may be causing some private equity buyers to walk away from the table.

July 12, 2018

Massive deals among top factors driving healthcare M&A activity

Strong earnings, megadeals and promising demographics are helping drive healthcare M&A activity.

July 12, 2018

Humana completes acquisitions of Kindred, Curo

Health insurance giant Humana—in a deal with private equity groups—closed its acquisitions of home health company Kindred Healthcare and hospice provider Curo Health Services.

July 12, 2018

Americans have mixed feelings about value of medical care

Americans generally agree science has improved the quality of healthcare, but the vast majority consider it unaffordable, according to a recent Pew Research Center survey.

July 12, 2018

CMS cuts funding for marketplace navigators for 2nd consecutive year

CMS announced it will award $10 million to the Navigator Program starting in the fall of 2018—representing a sharp decrease from $63 million in 2016.

July 11, 2018

Pfizer backs down on drug price increases, announces split into three businesses

Following attacks by President Trump on Twitter, drugmaker Pfizer backed down on its previously announced plan to raise drug prices on a number of prescriptions. Pfizer also announced Wednesday it will reorganize into three businesses, effective in 2019.

July 11, 2018

Amazon’s OTC business offers pills at steep discount

Retail giant Amazon is selling over-the-counter (OTC) medicines at lower prices than its brick-and-mortar competitors.

July 11, 2018

Trump’s Supreme Court nominee could face questions on healthcare record

Brett Kavanaugh, President Donald Trump’s pick to replace Supreme Court Justice Anthony Kennedy and a D.C. Appeals Court judge, will likely face questions on his healthcare record during confirmation hearings.

July 11, 2018

Around the web

Cardiovascular Business

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Cardiovascular Business

Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Cardiovascular Business

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing.